US Edition
UQ vaccine bought in billion-dollar deal - Campus Review
Summary by campusreview.com.au
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
UQ vaccine bought in billion-dollar deal - Campus Review
Breakthrough vaccine technology invented by the University of Queensland is at the centre of a landmark deal worth up to $1.6bn struck with global pharmaceutical giant Sanofi. Biotech company Vicebio was formed in 2018 to develop UQ’s proprietary Molecular Clamp technology – a vaccine delivery system that works like a clip, delivering the spike protein to a person’s immune system. Paris-based company Sanofi confirmed it would be acquiring Vicebi…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
